Narcolepsy epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
|||
| Line 11: | Line 11: | ||
===Prevalence=== | ===Prevalence=== | ||
*The [[prevalence]] of narcolepsy in white individuals from North America and Europe is estimated to be ~200–500 cases per million individuals.<ref name="pmid8210228">{{cite journal| author=Hublin C, Kaprio J, Partinen M, Koskenvuo M, Heikkila K, Koskimies S | display-authors=etal| title=The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort. | journal=Ann Neurol | year= 1994 | volume= 35 | issue= 6 | pages= 709-16 | pmid=8210228 | doi=10.1002/ana.410350612 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8210228 }} </ref><ref name="pmid11902429">{{cite journal| author=Silber MH, Krahn LE, Olson EJ, Pankratz VS| title=The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. | journal=Sleep | year= 2002 | volume= 25 | issue= 2 | pages= 197-202 | pmid=11902429 | doi=10.1093/sleep/25.2.197 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11902429 }} </ref><ref name="pmid12084885">{{cite journal| author=Ohayon MM, Priest RG, Zulley J, Smirne S, Paiva T| title=Prevalence of narcolepsy symptomatology and diagnosis in the European general population. | journal=Neurology | year= 2002 | volume= 58 | issue= 12 | pages= 1826-33 | pmid=12084885 | doi=10.1212/wnl.58.12.1826 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12084885 }} </ref> | |||
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. | *The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide. | ||
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | *In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | ||
Latest revision as of 07:22, 7 November 2020
|
Narcolepsy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Narcolepsy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Narcolepsy epidemiology and demographics |
|
Risk calculators and risk factors for Narcolepsy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Muhammad Waleed Haider, M.D.[2]
Overview
Epidemiology and Demographics
Incidence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
- The prevalence of narcolepsy in white individuals from North America and Europe is estimated to be ~200–500 cases per million individuals.[1][2][3]
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Hublin C, Kaprio J, Partinen M, Koskenvuo M, Heikkila K, Koskimies S; et al. (1994). "The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort". Ann Neurol. 35 (6): 709–16. doi:10.1002/ana.410350612. PMID 8210228.
- ↑ Silber MH, Krahn LE, Olson EJ, Pankratz VS (2002). "The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study". Sleep. 25 (2): 197–202. doi:10.1093/sleep/25.2.197. PMID 11902429.
- ↑ Ohayon MM, Priest RG, Zulley J, Smirne S, Paiva T (2002). "Prevalence of narcolepsy symptomatology and diagnosis in the European general population". Neurology. 58 (12): 1826–33. doi:10.1212/wnl.58.12.1826. PMID 12084885.